iRhythm Technologies Welcomes Engagement at Investor Conferences
iRhythm Technologies, Inc. (NASDAQ: IRTC), a prominent player in the digital healthcare landscape, is preparing to connect with investors at several key conferences in the near future. This engagement aims to provide insights into their cutting-edge solutions designed for disease detection, prevention, and prediction. With a commitment to enhancing patient health through innovative technology, iRhythm is set to present at notable industry gatherings.
Details of the Upcoming Conferences
iRhythm's management team will be showcasing their groundbreaking work at three major investor conferences.
Wells Fargo 2025 Healthcare Conference
This event is scheduled for a dynamic presentation on Wednesday, September 3, 2025. It begins at 12:45 p.m. Eastern Time. This conference primarily focuses on healthcare and provides a platform for discussing advancements that could shape the future of medical technology.
Morgan Stanley Global Healthcare Conference 2025
Following the Wells Fargo event, iRhythm will take part in the Morgan Stanley Global Healthcare Conference on Tuesday, September 9, 2025. Their session will commence at 2:35 p.m. Eastern Time, inviting a broad audience to learn more about their impactful solutions.
Baird 2025 Global Healthcare Conference
Lastly, they will participate in the Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025. This presentation is set for 12:50 p.m. Eastern Time, and it will further highlight iRhythm's innovative contributions to digital health.
Accessing the Presentations
Investors and interested parties can access live and archived webcasts of these presentations via the “Events & Presentations” section of iRhythm's investor website. This allows stakeholders to stay informed about the advancements in iRhythm's technology and their plans for future innovations.
About iRhythm Technologies, Inc.
Founded with a vision to revolutionize patient care, iRhythm Technologies combines cutting-edge wearable biosensors and cloud-based analytics with proprietary algorithms. Their technology transforms data from millions of heartbeats into valuable insights that enhance clinical decision-making. iRhythm's focus on delivering reliable, actionable health information sets it apart in the rapidly evolving healthcare landscape.
Contact iRhythm for More Information
If you wish to learn more or have any inquiries, you can reach out to their investor relations team. For investor-related questions, please contact Stephanie Zhadkevich directly via email at investors@irhythmtech.com. Media inquiries can be directed to Kassandra Perry at irhythm@highwirepr.com.
Frequently Asked Questions
What is the purpose of the investor conferences?
The conferences offer a platform for iRhythm Technologies to present its innovative healthcare solutions and engage with investors and industry stakeholders.
When is iRhythm’s presentation at the Wells Fargo Conference?
The presentation at the Wells Fargo 2025 Healthcare Conference is scheduled for September 3, 2025, at 12:45 p.m. Eastern Time.
How can I access the conference presentations?
Live and archived webcasts of the presentations will be available on the “Events & Presentations” section of iRhythm's investor website.
What distinguishes iRhythm Technologies in the healthcare industry?
iRhythm stands out with its integration of wearable technology and advanced analytics, providing actionable insights from heart monitoring data which enhance patient care.
Who can I contact for investor relations at iRhythm?
You can contact Stephanie Zhadkevich at investors@irhythmtech.com for any investor-related inquiries.
